Novel imidazopyrimidines-based molecules induce tetramerization of tumor pyruvate kinase M2 and exhibit potent antiproliferative profile

Sagarkumar Patel(National Institute of Pharmaceutical Education and Research), Amit Shard(National Institute of Pharmaceutical Education and Research)
European Journal of Pharmaceutical Sciences
December 28, 2021
10.1016/j.ejps.2021.106112
Cited by 39

Related Papers

Emerging therapies and management approaches in sickle cell disease (SCD): A critical review
|Journal of Phytonanotechnology and Pharmaceutical Sciences|2023|9
Simultaneous determiantion of aripiprazole and escitalopram oxalate by HPLC
|Journal of Chemical Metrology|2023|1
IMMUNOGENICITY IN PRECLINICAL DRUG DEVELOPMENT: STRATEGIES, RISKS, AND IMPLICATIONS FOR LARGE MOLECULE-BASED BIOLOGICS INCLUDING CAR T-CELL AND GENE THERAPIES
|Unknown|2023|0